ATE136900T1 - Prolinderivat von rapamycin, seine herstellung und verwendung - Google Patents
Prolinderivat von rapamycin, seine herstellung und verwendungInfo
- Publication number
- ATE136900T1 ATE136900T1 AT93307553T AT93307553T ATE136900T1 AT E136900 T1 ATE136900 T1 AT E136900T1 AT 93307553 T AT93307553 T AT 93307553T AT 93307553 T AT93307553 T AT 93307553T AT E136900 T1 ATE136900 T1 AT E136900T1
- Authority
- AT
- Austria
- Prior art keywords
- rapamycin
- preparation
- proline derivative
- norrapamycin
- proline
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Transplantation (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US94996492A | 1992-09-24 | 1992-09-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE136900T1 true ATE136900T1 (de) | 1996-05-15 |
Family
ID=25489754
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT93307553T ATE136900T1 (de) | 1992-09-24 | 1993-09-23 | Prolinderivat von rapamycin, seine herstellung und verwendung |
Country Status (11)
Country | Link |
---|---|
US (1) | US5441977A (de) |
EP (1) | EP0589703B1 (de) |
JP (1) | JPH06192269A (de) |
KR (1) | KR940007041A (de) |
AT (1) | ATE136900T1 (de) |
CA (1) | CA2106034A1 (de) |
DE (1) | DE69302249T2 (de) |
DK (1) | DK0589703T3 (de) |
ES (1) | ES2085726T3 (de) |
GR (1) | GR3020093T3 (de) |
HU (1) | HUT70207A (de) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA935112B (en) * | 1992-07-17 | 1994-02-08 | Smithkline Beecham Corp | Rapamycin derivatives |
USRE37421E1 (en) | 1993-07-16 | 2001-10-23 | Smithkline Beecham Corporation | Rapamycin derivatives |
EP0854874B1 (de) * | 1994-11-10 | 2003-05-02 | Pfizer Inc. | Macrocyklische lactonverbindungen und verfahren zu ihrer herstellung |
GB9710962D0 (en) * | 1997-05-28 | 1997-07-23 | Univ Cambridge Tech | Polyketides and their synthesis |
US6709873B1 (en) | 1997-04-09 | 2004-03-23 | Isodiagnostika Inc. | Method for production of antibodies to specific sites of rapamycin |
US8790391B2 (en) | 1997-04-18 | 2014-07-29 | Cordis Corporation | Methods and devices for delivering therapeutic agents to target vessels |
US6273913B1 (en) * | 1997-04-18 | 2001-08-14 | Cordis Corporation | Modified stent useful for delivery of drugs along stent strut |
EE200000253A (et) | 1997-10-22 | 2001-06-15 | Ponikau Jens | Seentevastase toimeaine kasutamine ravimite valmistamiseks, mis on ette nähtud mitteinvasiivsetest seenorganismidest tingitud haiguste raviks või vältimiseks |
US6399648B1 (en) | 1998-08-14 | 2002-06-04 | Gpi Nil Holdings, Inc. | N-oxides of heterocyclic ester, amide, thioester, or ketone for vision and memory disorders |
US7410995B1 (en) | 1998-08-14 | 2008-08-12 | Gpi Nil Holdings Inc. | N-linked sulfonamide of heterocyclic thioesters for vision and memory disorders |
US6335348B1 (en) | 1998-08-14 | 2002-01-01 | Gpi Nil Holdings, Inc. | Nitrogen-containing linear and azepinyl/ compositions and uses for vision and memory disorders |
US7338976B1 (en) | 1998-08-14 | 2008-03-04 | Gpi Nil Holdings, Inc. | Heterocyclic esters or amides for vision and memory disorders |
US6337340B1 (en) | 1998-08-14 | 2002-01-08 | Gpi Nil Holdings, Inc. | Carboxylic acids and isosteres of heterocyclic ring compounds having multiple heteroatoms for vision and memory disorders |
US6333340B1 (en) | 1998-08-14 | 2001-12-25 | Gpi Nil Holdings, Inc. | Small molecule sulfonamides for vision and memory disorders |
US6506788B1 (en) | 1998-08-14 | 2003-01-14 | Gpi Nil Holdings, Inc. | N-linked urea or carbamate of heterocyclic thioesters for vision and memory disorders |
US6376517B1 (en) | 1998-08-14 | 2002-04-23 | Gpi Nil Holdings, Inc. | Pipecolic acid derivatives for vision and memory disorders |
US6218423B1 (en) | 1998-08-14 | 2001-04-17 | Gpi Nil Holdings, Inc. | Pyrrolidine derivatives for vision and memory disorders |
US6384056B1 (en) | 1998-08-14 | 2002-05-07 | Gpi Nil Holdings, Inc. | Heterocyclic thioesters or ketones for vision and memory disorders |
US6339101B1 (en) | 1998-08-14 | 2002-01-15 | Gpi Nil Holdings, Inc. | N-linked sulfonamides of N-heterocyclic carboxylic acids or isosteres for vision and memory disorders |
US7265150B1 (en) | 1998-08-14 | 2007-09-04 | Gpi Nil Holdings Inc. | Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds for vision and memory disorders |
US8236048B2 (en) | 2000-05-12 | 2012-08-07 | Cordis Corporation | Drug/drug delivery systems for the prevention and treatment of vascular disease |
US20060222756A1 (en) * | 2000-09-29 | 2006-10-05 | Cordis Corporation | Medical devices, drug coatings and methods of maintaining the drug coatings thereon |
DE60124285T3 (de) | 2000-09-29 | 2011-03-17 | Cordis Corp., Miami Lakes | Beschichtete medizinische geräte |
US20070276473A1 (en) * | 2000-09-29 | 2007-11-29 | Llanos Gerard H | Medical Devices, Drug Coatings and Methods for Maintaining the Drug Coatings Thereon |
MXPA06011883A (es) * | 2004-04-14 | 2006-12-14 | Wyeth Corp | 42-ester de prolina-rapamicina con acido 2,2-bis(hidroximetil)propionico y sintesis enzimatica de dos etapas de 42-ester de prolina-rapamicina con acido 2,2-bis(hidroximetil)propionico y 42-ester de rapamicina con acido 2,2-bis(hidroximetil)propionic |
GB0417852D0 (en) * | 2004-08-11 | 2004-09-15 | Biotica Tech Ltd | Production of polyketides and other natural products |
WO2010011882A1 (en) * | 2008-07-25 | 2010-01-28 | Wyeth | Biosynthetic gene cluster for the production of a complex polyketide |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA737247B (en) * | 1972-09-29 | 1975-04-30 | Ayerst Mckenna & Harrison | Rapamycin and process of preparation |
US3993749A (en) * | 1974-04-12 | 1976-11-23 | Ayerst Mckenna And Harrison Ltd. | Rapamycin and process of preparation |
US4885171A (en) * | 1978-11-03 | 1989-12-05 | American Home Products Corporation | Use of rapamycin in treatment of certain tumors |
US4316885A (en) * | 1980-08-25 | 1982-02-23 | Ayerst, Mckenna And Harrison, Inc. | Acyl derivatives of rapamycin |
US4401653A (en) * | 1981-03-09 | 1983-08-30 | Ayerst, Mckenna & Harrison Inc. | Combination of rapamycin and picibanil for the treatment of tumors |
US4375464A (en) * | 1981-11-19 | 1983-03-01 | Ayerst, Mckenna & Harrison Inc. | Antibiotic AY24,668 and process of preparation |
US4650803A (en) * | 1985-12-06 | 1987-03-17 | University Of Kansas | Prodrugs of rapamycin |
JP2799208B2 (ja) * | 1987-12-09 | 1998-09-17 | フアイソンズ・ピーエルシー | マクロ環状化合物 |
US5100899A (en) * | 1989-06-06 | 1992-03-31 | Roy Calne | Methods of inhibiting transplant rejection in mammals using rapamycin and derivatives and prodrugs thereof |
WO1991002736A1 (en) * | 1989-08-18 | 1991-03-07 | Fisons Plc | Macrocyclic compounds |
US5023262A (en) * | 1990-08-14 | 1991-06-11 | American Home Products Corporation | Hydrogenated rapamycin derivatives |
CA2051872A1 (en) * | 1990-09-24 | 1992-03-25 | Kevin M. Byrne | Directed biosynthesis process for prolyl-immunomycin |
US5078999A (en) * | 1991-02-22 | 1992-01-07 | American Home Products Corporation | Method of treating systemic lupus erythematosus |
US5080899A (en) * | 1991-02-22 | 1992-01-14 | American Home Products Corporation | Method of treating pulmonary inflammation |
IL101353A0 (en) * | 1991-04-03 | 1992-11-15 | American Home Prod | Pharmaceutical compositions for treating diabetes |
US5100883A (en) * | 1991-04-08 | 1992-03-31 | American Home Products Corporation | Fluorinated esters of rapamycin |
US5147877A (en) * | 1991-04-18 | 1992-09-15 | Merck & Co. Inc. | Semi-synthetic immunosuppressive macrolides |
US5091389A (en) * | 1991-04-23 | 1992-02-25 | Merck & Co., Inc. | Lipophilic macrolide useful as an immunosuppressant |
US5102876A (en) * | 1991-05-07 | 1992-04-07 | American Home Products Corporation | Reduction products of rapamycin |
-
1993
- 1993-09-13 CA CA002106034A patent/CA2106034A1/en not_active Abandoned
- 1993-09-22 HU HU9302675A patent/HUT70207A/hu unknown
- 1993-09-22 JP JP5236267A patent/JPH06192269A/ja active Pending
- 1993-09-23 KR KR1019930019384A patent/KR940007041A/ko not_active Application Discontinuation
- 1993-09-23 DK DK93307553.3T patent/DK0589703T3/da active
- 1993-09-23 EP EP93307553A patent/EP0589703B1/de not_active Expired - Lifetime
- 1993-09-23 ES ES93307553T patent/ES2085726T3/es not_active Expired - Lifetime
- 1993-09-23 DE DE69302249T patent/DE69302249T2/de not_active Expired - Fee Related
- 1993-09-23 AT AT93307553T patent/ATE136900T1/de not_active IP Right Cessation
-
1994
- 1994-03-01 US US08/204,028 patent/US5441977A/en not_active Expired - Lifetime
-
1996
- 1996-05-30 GR GR960401449T patent/GR3020093T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
KR940007041A (ko) | 1994-04-26 |
ES2085726T3 (es) | 1996-06-01 |
EP0589703B1 (de) | 1996-04-17 |
HUT70207A (en) | 1995-09-28 |
US5441977A (en) | 1995-08-15 |
CA2106034A1 (en) | 1994-03-25 |
JPH06192269A (ja) | 1994-07-12 |
EP0589703A1 (de) | 1994-03-30 |
HU9302675D0 (en) | 1993-12-28 |
DK0589703T3 (da) | 1996-05-13 |
DE69302249D1 (de) | 1996-05-23 |
DE69302249T2 (de) | 1996-09-19 |
GR3020093T3 (en) | 1996-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE136900T1 (de) | Prolinderivat von rapamycin, seine herstellung und verwendung | |
DE69426831D1 (de) | Heterocyclische ester von rapamycin und sie enthaltende pharmazeutische zusammensetzungen | |
DE69419032D1 (de) | Gehinderte ester von rapamycin und ihre verwendung als arzneimittel | |
ES2069137T3 (es) | Derivados de imidazopiridina y su uso. | |
DE69230824D1 (de) | Neue tetrapeptidderivate | |
AU5082790A (en) | Triazine derivative and herbicide containing the same as active ingredient | |
DE59310236D1 (de) | 5-aryl-1,3-thiazin derivate, deren herstellung und deren verwendung als schädlingsbekämpfungsmittel | |
DE69428142D1 (de) | Quinolin- oder Quinazolinderivate, deren Herstellung und Verwendung | |
ES2177583T3 (es) | Nuevo compuesto tetraciclico. | |
ES2096941T3 (es) | 27-hidroxirrapamicina y derivados de la misma. | |
ES2093037T3 (es) | Derivados de beta-lactama y su preparacion. | |
DE68912438D1 (de) | Antifungale Antibiotika. | |
ATE156486T1 (de) | Fungizide 3,4-diaryl-(5h)-furan-2-onederivate | |
ES2128335T3 (es) | Derivados de imidazo(1,2-c)quinazolina como antihipertensivos y antidisuricos. | |
AU7244287A (en) | Fungicidal pyridyl cyclopropane carboxamides | |
DK0713702T3 (da) | Anxiolytisk middel | |
ATE197953T1 (de) | Pyrrolo(4,3,2-de)chinolin-derivat | |
DE69104646D1 (de) | 2-Fluorneplanocin A und seine Herstellung. | |
FI934920A0 (fi) | Gjutstycke, foerfarande foer dess framstaellning och anvaendning av det |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |